<DOC>
	<DOCNO>NCT02806739</DOCNO>
	<brief_summary>The purpose study assess feasibility randomize pregnant woman high risk gestational diabetes 24-week period soy food consumption . This study also examine effect soy protein isoflavones glucose metabolism lipid level among pregnant woman high risk gestational diabetes , child 's weight height birth 6 week life .</brief_summary>
	<brief_title>Soy Supplementation Gestational Diabetes</brief_title>
	<detailed_description>Evidence animal study , human observational study , randomize control trial suggest soy protein isoflavones beneficial effect lipid glucose metabolism . Additionally , soy isoflavones diffuse across placenta , enter fetal circulation potentially reduce susceptibility cardiometabolic disorder adulthood . Given high prevalence GDM serious health consequence woman child , likely health benefit soy protein isoflavones panel metabolic parameter , role maternal supplementation soy protein isoflavones prevention GDM and/or minimization GDM severity mother improve health indicator offspring merit investigation . This study provide new essential information efficacy feasibility use soy-based whole food prevent manage gestational diabetes development . This study randomize , placebo-controlled trial . Forty pregnant woman high risk gestational diabetes recruit obstetrics service Melrose Wakefield Hospital Tufts Medical Center , randomize receive soy-based food minimize soy intake , 16th gestational week birth . To measure participant ' compliance treatment , study use three method : ( 1 ) monthly telephone interview adherence treatment ; ( 2 ) daily soy food intake log ; ( 3 ) serum isoflavone concentration . To evaluate effect soy supplementation GDM , study collect blood sample measure glucose , insulin , HbA1c , lipid ( triglyceride , total cholesterol , high-density lipoprotein cholesterol low-density lipoprotein cholesterol ) . The study also measure weight body composition participate pregnant woman participant ' respective child 's weight , length body composition .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>Age &gt; =18 year ≤ 18 week pregnancy Singleton pregnancy Have least one risk factor GDM , include overweight ( BMI ≥ 25 kg/m2 ) pregnancy , firstdegree relative type2 diabetes mellitus ( T2DM ) , abnormal glucose tolerance/GDM previous pregnancy , and/or history macrosomia ( birth weight ≥ 4,000 gram ) previous pregnancy Being able willing give write informed consent . Allergic soy milk product Current smoker Preexisting diabetes outside pregnancy heath condition could affect glucose level Chronic serious medical condition hypertension , heart disease , stroke , chronic renal hepatic disease , malignant disease ( selfreport medical record review ) Use medication could interfere insulin secretion insulin sensitivity Weight loss pregnancy 10 % prepregnancy body weight Current severe nausea and/or vomiting ( selfreport ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Soy protein</keyword>
	<keyword>isoflavones</keyword>
	<keyword>gestational diabetes</keyword>
</DOC>